Maternal Toxemia Is Associated With Reduced Incidence of Germinal Matrix Hemorrhage in Premature Babies

Abstract

To evaluate prenatal and perinatal risk factors for development of germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH), we conducted a prospective epidemiologic study of 449 babies whose birth weight was less than 1501 grams. This study permitted us to test our previously generated hypothesis that babies born to mothers with preeclampsia were at substantially reduced risk of developing GMH-IVH. Seventy-two (16%) of the babies in this population developed GMH-IVH. One (2.5%) of the 40 mothers with a diagnosis of preeclampsia and 71 (17.4%) of 409 mothers without preeclampsia gave birth to babies who developed GMH-IVH. GMH-IVH was seen in 6/107 (5.6%) of babies born to women with hypertension including 4/69 (5.8%) of babies born to women with pregnancy-induced hypertension, compared to 66/352 (18.8%) of babies born to mothers who did not have hypertension. Only 7.3% (8/108) of babies born to women who had proteinuria had GMH-IVH, compared to 18.3% (64/350) of babies whose mothers did not have proteinuria. GMH-IVH was seen in 5/89 (5.6%) of babies whose mothers had both hypertension and proteinuria, whereas 63/332 (19%) of babies born to mothers who lacked both factors, developed GMH-IVH. In stepwise logistic regression analysis, these significant findings were not explained by the presence of labor, postnatal acidemia, need for intubation, antenatal administration of steroids, birth weight, or gestational age. In addition, we found that maternal receipt of magnesium sulfate was associated with diminished risk of GMH-IVH even in those babies born to mothers who apparently did not have preeclampsia. We postulate that the association of preeclampsia and GVH-IVH may be related to prostaglandin effects. Reduced maternal, placental, and umbilical prostaglandin I₂ (PGI₂) values are characteristic of women with preeclampsia. Thus, babies born to mothers with preeclampsia may have a physiologic state similar to those having received indomethacin, a cyclooxygenase blocker that causes diminished PGI₂ levels and an effective GMH-IVH prophylactic agent. We conclude that early third-trimester maternal preeclampsia/toxemia is associated with reduced risk of GMH-IVH in the preterm newborn. (J Child Neurol 1992;7:70-76).

Get full access to this article

View all access options for this article.

References

Volpe JJ : Intraventricular hemorrhage in the premature infant. Current concepts. Part I. Ann Neurol 1989;25:1-11.

Leviton A. , Kuban K. , Pagano M. : Maternal toxemia and neonatal germinal matrix hemorrhage in intubated infants less than 1750 grams. Obstet Gynecol 1988;72:571-576.

Sibai BM : Pitfalls in diagnosis and management of preeclampsia. Am J Obstet Gynecol 1988;159:1-5.

Morgan MA , Thurnau GR : Pregnancy-induced hypertension without proteinuria: Is it true preeclampsia? South Med J 1988;81:210-213.

Redman CW , Jefferies M. : Revised definition of pre-eclampsia. Lancet 1988;1:809-812.

Davey DA , MacGillivray I. : The classification and definition of the hypertensive disorders of pregnancy . Am J Obstet Gynecol 1988;158:892-898.

van de Bor M. , Verloove-Vanhorick SP , Brand R. , et al: Incidence and prediction of periventricular-intraventricular hemorrhage in very preterm infants. J Perinat Med 1987; 15:333-339.

Feinstein AR : Scientific standards in epidemiologic studies of the menace of daily life. Science 1988;242:1257-1263.

Hill AB : The environment and disease: Association or causation. Proc R Soc Med 1965;58:295.

10.

Romero R. , Lockwood C. , Oyarzun E. , et al: Toxemia: New concepts in an old disease. Semin Perinatol 1988;12:302-323.

11.

Benigni A. , Gregorini G. , Frusca T. , et al: Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension . N Engl J Med 1989;321:357-362.

12.

Schiff E. , Peleg E. , Goldenberg M. , et al: The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989;321:351-356.

13.

Ment LR , Duncan CC , Ehrenkranz RA , et al: Randomized low-dose Indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr 1988;112:948-955.

14.

Bada HS , Green RS , Pourcyrous M. , et al: Indomethacin reduces the risks of severe intraventricular hemorrhage . J Pediatr 1989;115:631-637.

15.

Bandstra ES , Montalvo BM , Goldberg RN , et al: Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants . Pediatrics 1988;82:533-542.

16.

Ment LR , Stewart WB , Scott DT , Duncan CC : Beagle puppy model of intraventricular hemorrhage: Randomized indomethacin prevention trial. Neurology 1983;33:179-184.

17.

Hanigan WC , Kennedy G. , Roemisch F. , et al: Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr 1988;112:941-947.

18.

Avery ME , Aylward G. , Creasy R. , et al: Update on prenatal steroid for prevention of respiratory distress: Report of a conference—September 26-28, 1985. Am J Obstet Gynecol 1986;155:2-5.

19.

Van Marter LJ , Leviton A. , Kuban K. , et al: Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics 1990;86:331-336.

20.

Doyle LW , Kitchen WH , Ford GW , et al: Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J Pediatr 1986;108:287-292.

21.

Leviton A. , Pagano M. , Kuban K. : Etiologic heterogeneity of intracranial hemorrhage in preterm newborns . Pediatr Neurol 1988;4:274-278.

22.

Chiswick ML : Prolonged rupture of membranes, pre-eclamptic toxemia and respiratory distress syndrome. Arch Dis Child 1976;51:674-679.

23.

Lee KS , Eidelman AT , Tseng PI , et al: Respiratory distress syndrome of the newborn and complications of pregnancy. Pediatrics 1976;58:675-680.

24.

Yoon JJ , Kohl S. , Harper RG : The relationship between maternal hypertensive disease of pregnancy and the incidence of idiopathic respiratory distress syndrome. Pediatrics 1980; 65:735-739.

25.

Purohit DM , Ellison RC , Zierler S. , et al: Risk factors for retrolental fibroplasia: Experience with 3,025 premature infants. National collaborative study on patent ductus arteriosus in premature Infants. Pediatrics 1985;76:339-344.

26.

Gluck L. , Kulovich MV : The evaluation of functional maturity, in Gluck L (ed). Modern Perinatal Medicine. Chicago , Year Book, 1974, pp 195-207.

27.

Hadi HA : Fetal cerebral maturation in hypertensive disorders of pregnancy. Obstet Gynecol 1984;63:214-219.

28.

Chesley LC , Sibai BM : Clinical significance of elevated mean arterial pressure in the second trimester . Am J Obstet Gynecol 1988;159:275-279.

29.

deCrespigny LC , MacKay R. , Murton LJ , et al: Timing of neonatal cerebroventricular hemorrhage with ultrasound. Arch Dis Child 1982;57:231-233.

30.

Dolfin T. , Skidmore MB , Fong KW , et al: Incidence, severity, and timing of subependymal and intraventricular hemorrhages in preterm infants born in a perinatal unit as detected by serial real-time ultrasound. Pediatrics 1983;71:541-546.

31.

Beverly DW , Chance GW , Coates CF : Intraventricular haemorrhage—timing of occurrence and relationship to perinatal events. Br J Obstet Gynaecol 1984 ;91:1007-1013.

32.

McDonald MM , Koops BL , Johnson ML et al: Timing and antecedents of intracranial hemorrhage in the newborn. Pediatrics 1984 ;74:32-36.

33.

Page EW , Christianson R. : Influence of blood pressure changes with and without proteinuria upon outcome of pregnancy. Am J Obstet Gynecol 1976;126:821-833.

34.

Mutch Lmm , Moar VA , Ounsted MK , Redman CW : Hypertension during pregnancy, with and without specific hypotensive treatment. I. Perinatal factors and neonatal morbidity. Early Hum Dev 1977;1:47-57.

35.

Ounsted MK , Moar VA , Good FJ : Hypertension during pregnancy with and without specific treatment: The development of the children at the age of four years. Br J Obstet Gynaecol 1980;87:19-24.

36.

Sibai BM , Anderson GD , Abdella TN , et al: Eclampsia. III. Neonatal outcome, growth, and development. Am J Obstet Gynecol 1983;146:307-316.

37.

Miettinen OS : Efficacy of therapeutic practice: Will epidemiology provide the answers? in Melmon KL (ed): Drug Therapeutics—Concepts for Physicians. New York , Elseiver -North Holland, 1980, pp 201-208.